Prime Medicine, Common Etf Market Value
| PRME Etf | USD 3.33 0.13 4.06% |
| Symbol | Prime |
The market value of Prime Medicine, Common is measured differently than its book value, which is the value of Prime that is recorded on the company's balance sheet. Investors also form their own opinion of Prime Medicine,'s value that differs from its market value or its book value, called intrinsic value, which is Prime Medicine,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Prime Medicine,'s market value can be influenced by many factors that don't directly affect Prime Medicine,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Prime Medicine,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Prime Medicine, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Prime Medicine,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Prime Medicine, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Prime Medicine,'s etf what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Prime Medicine,.
| 12/07/2022 |
| 11/26/2024 |
If you would invest 0.00 in Prime Medicine, on December 7, 2022 and sell it all today you would earn a total of 0.00 from holding Prime Medicine, Common or generate 0.0% return on investment in Prime Medicine, over 720 days. Prime Medicine, is related to or competes with Beam Therapeutics, Caribou Biosciences, Intellia Therapeutics, Sana Biotechnology, Ginkgo Bioworks, Ocean Biomedical, and Royalty Pharma. Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing ... More
Prime Medicine, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Prime Medicine,'s etf current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Prime Medicine, Common upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 25.8 | |||
| Value At Risk | (9.09) | |||
| Potential Upside | 7.74 |
Prime Medicine, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Prime Medicine,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Prime Medicine,'s standard deviation. In reality, there are many statistical measures that can use Prime Medicine, historical prices to predict the future Prime Medicine,'s volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.51) | |||
| Total Risk Alpha | (1.09) | |||
| Treynor Ratio | (0.13) |
Prime Medicine, Common Backtested Returns
Prime Medicine, Common maintains Sharpe Ratio (i.e., Efficiency) of -0.0459, which implies the entity had a -0.0459% return per unit of risk over the last 3 months. Prime Medicine, Common exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Prime Medicine,'s Coefficient Of Variation of (2,028), risk adjusted performance of (0.03), and Variance of 27.07 to confirm the risk estimate we provide. The etf holds a Beta of 2.05, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Prime Medicine, will likely underperform.
Auto-correlation | 0.74 |
Good predictability
Prime Medicine, Common has good predictability. Overlapping area represents the amount of predictability between Prime Medicine, time series from 7th of December 2022 to 2nd of December 2023 and 2nd of December 2023 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Prime Medicine, Common price movement. The serial correlation of 0.74 indicates that around 74.0% of current Prime Medicine, price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.74 | |
| Spearman Rank Test | 0.65 | |
| Residual Average | 0.0 | |
| Price Variance | 3.1 |
Prime Medicine, Common lagged returns against current returns
Autocorrelation, which is Prime Medicine, etf's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Prime Medicine,'s etf expected returns. We can calculate the autocorrelation of Prime Medicine, returns to help us make a trade decision. For example, suppose you find that Prime Medicine, has exhibited high autocorrelation historically, and you observe that the etf is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Prime Medicine, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Prime Medicine, etf is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Prime Medicine, etf is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Prime Medicine, etf over time.
Current vs Lagged Prices |
| Timeline |
Prime Medicine, Lagged Returns
When evaluating Prime Medicine,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Prime Medicine, etf have on its future price. Prime Medicine, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Prime Medicine, autocorrelation shows the relationship between Prime Medicine, etf current value and its past values and can show if there is a momentum factor associated with investing in Prime Medicine, Common.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Prime Etf
Prime Medicine, financial ratios help investors to determine whether Prime Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Prime with respect to the benefits of owning Prime Medicine, security.